Table 3. Regression analysis of miRNA in non-recurrent and recurrent tumor relative to their normal adjacent tissue.
Recurrent Tumor (n = 8) compared to Non-Recurrent Tumor (n = 6): | |||||
miRNA | Fold Change | P | miRNA | Fold Change | P |
hsa-let-7b | −48.7 | 0.027 | hsa-miR-125a-3p | 12.4 | 0.0001 |
hsa-miR-106b* | −9.7 | 0.017 | hsa-miR-589 | 4.6 | 0.0015 |
hsa-miR-187 | −7.8 | 0.036 | hsa-miR-450a | 6.2 | 0.0044 |
hsa-miR-650 | −4.7 | 0.049 | hsa-miR-211 | 13.8 | 0.0117 |
hsa-miR-886-5p | −1.7 | 0.048 | hsa-miR-139-3p | 10.9 | 0.0128 |
After normalizing miRNA expression in each adenocarcinoma to endogenous control RNU48, they were normalized to the expression in the corresponding matched adjacent normal control lung tissue. Limma [9] was then used to identify differentially expressed miRNA between tumors that did and did not recur and calculate p values.